Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Eur Heart J. 2019 Feb 1;40(5):476-484. doi: 10.1093/eurheartj/ehy641.
To undertake a systematic review and meta-analysis to determine the influence of tricuspid regurgitation (TR) severity on mortality.
We performed a systematic search for studies reporting clinical outcomes of patients with TR. The primary endpoint was all-cause mortality and secondary endpoints were cardiac mortality and hospitalization for heart failure (HF). Overall risk ratios (RR) and 95% confidence intervals (CIs) were derived for each endpoint according to the severity of TR by meta-analysing the effect estimates of eligible studies. Seventy studies totalling 32 601 patients were included in the analysis, with a mean (±SD) follow-up of 3.2 ± 2.1 years. Moderate/severe TR was associated with a two-fold increased mortality risk compared to no/mild TR (RR 1.95, 95% CI 1.75-2.17). Moderate/severe TR remained associated with higher all-cause mortality among 13 studies which adjusted for systolic pulmonary arterial pressures (RR 1.85, 95% CI 1.44-2.39), and 15 studies, which adjusted for right ventricular (RV) dysfunction (RR 1.78, 95% CI 1.49-2.13). Moderate/severe TR was also associated with increased cardiac mortality (RR 2.56, 95% CI 1.84-3.55) and HF hospitalization (RR 1.73, 95% CI 1.14-2.62). Compared to patients with no TR, patients with mild, moderate, and severe TR had a progressively increased risk of all-cause mortality (RR 1.25, 1.61, and 3.44, respectively; P < 0.001 for trend).
Moderate/severe TR is associated with an increased mortality risk, which appears to be independent of pulmonary pressures and RV dysfunction.
进行系统评价和荟萃分析,以确定三尖瓣反流(TR)严重程度对死亡率的影响。
我们对报告 TR 患者临床结局的研究进行了系统检索。主要终点是全因死亡率,次要终点是心脏死亡率和心力衰竭(HF)住院率。根据 TR 严重程度对符合条件的研究的效应估计值进行荟萃分析,得出每个终点的总体风险比(RR)和 95%置信区间(CI)。共纳入 70 项研究,总计 32601 例患者,平均(±SD)随访 3.2±2.1 年。与无/轻度 TR 相比,中度/重度 TR 患者的死亡率风险增加了一倍(RR 1.95,95%CI 1.75-2.17)。在调整了收缩压肺动脉压(RR 1.85,95%CI 1.44-2.39)的 13 项研究和调整了右心室(RV)功能障碍(RR 1.78,95%CI 1.49-2.13)的 15 项研究中,中度/重度 TR 仍与较高的全因死亡率相关。中度/重度 TR 还与增加的心脏死亡率(RR 2.56,95%CI 1.84-3.55)和 HF 住院率(RR 1.73,95%CI 1.14-2.62)相关。与无 TR 的患者相比,轻度、中度和重度 TR 的患者全因死亡率的风险逐渐增加(RR 分别为 1.25、1.61 和 3.44;P<0.001 趋势)。
中度/重度 TR 与死亡率增加相关,且似乎独立于肺动脉压和 RV 功能障碍。